Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Hovione was a founding member of iBET in 1989 and has just re-joined the Instituto de Biologia Experimental e Tecnológica. In order to increase the scope and strength of its research and development programs in the areas of novel and high potential ...
read more
Hovione, a provider of spray drying and particle engineering services, announced an exclusive license agreement for a preclinical ophthalmology program, JX08, with Ji Xing Pharmaceuticals Limited (JIXING).
read more
Wednesday, March 22, 2023
Hovione and Laxxon Medical announced a collaboration to advance the use of 3D screen printing technologies for the pharma industry.
read more
Hovione and Merrion Pharmaceuticals [ESM; MERR] announced today that they have concluded a strategic partnership directed to the use of Merrion’s patented GIPET absorption enhancing technology by Hovione clients. Hovione, an international contract ...
read more
Thursday, September 25, 2025
Hovione and Microinnova Engineering announced a partnership to advance the development of multi-purpose, plug-and-play modular equipment for flow chemistry.
read more
Hovione and Ripple Therapeutics have entered into a strategic partnership to expand the use of Ripple's Epidel® platform beyond ophthalmic applications.
read more
Tuesday, February 22, 2022
Hovione a provider of spray drying and particle engineering, announced a strategic partnership with Zerion Pharma to market and commercialize Dispersome®, Zerion´s proprietary solubility enhancement technology platform.
read more
Hovione announced the appointment of Dr. Jean-Luc Herbeaux as Chief Operating Officer (COO), effective May 1st, 2020.
read more
Wednesday, September 30, 2020
Hovione announced the signing of a partnership agreement with Ligand to ramp up the production output of Captisol.
read more
Hovione announced a new MG2 Tekna Precision Capsule filling unit is now online in its Portugal facilities.
read more
Hovione will initiate recruitment for its Phase 1 clinical trial of HY02, a proprietary minocycline sterile ointment to treat a subset of ocular surface inflammation, generally manifesting on the inner edge of the eyelids, leading to eye irritation ...
read more
Friday, September 20, 2019
Hovione announced details of its planned Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.
read more
Hovione today announced the appointment of Dr. Justin Hughey to lead the Particle Design sciences at our site in New Jersey. With over 30 publications, posters and book chapters Dr. Hughey is an acknowledged expert in the field of solubilization ...
read more
Wednesday, September 27, 2017
Hovione announced today the appointment of Frédéric Kahn as Vice President Marketing and Sales.
read more
Hovione today announced the appointment of Dr. Filipe Gaspar as Vice President of its Research and Development organization. Dr. Gaspar will lead teams based in Lisbon and New Jersey that serve our clients’ drug development projects; he will also be...
read more